Jennifer Gudeman
Chief Tech/Sci/R&D Officer presso AVADEL PHARMACEUTICALS PLC
Posizioni attive di Jennifer Gudeman
Società | Posizione | Inizio | Fine |
---|---|---|---|
AVADEL PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 07/12/2020 | - |
Storia della carriera di Jennifer Gudeman
Precedenti posizioni note di Jennifer Gudeman
Società | Posizione | Inizio | Fine |
---|---|---|---|
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/01/2003 | - |
Formazione di Jennifer Gudeman
St. Louis College of Pharmacy | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Irlanda | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AVADEL PHARMACEUTICALS PLC | Health Technology |
Aziende private | 2 |
---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Gudeman
- Esperienza